Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention
30 August 2016 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker

Zealand University Hospital, Roskilde (Denmark)
23 More presentations in this session
Access the full session
The Event
ESC Congress 2016
30 August 2016
08:30 CET
